Serum albumin enhances bone healing in a nonunion femoral defect model in rats: A computer tomography micromorphometry study

Gábor Skaliczki, Károly Schandl, Miklós Weszl, T. Major, Miklós Kovács, József Skaliczki, M. Szendrői, Csaba Dobó-Nagy, Z. Lacza

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose: Blood-derived proliferative factors such as platelet rich plasma or activated plasma are promising adjuvants for bone grafts. Our earlier studies showed that serum albumin itself can markedly enhance the proliferation of stem cells on bone allograft and postulated that albumin coating alone may improve bone graft integration in vivo. Methods: Two femoral defect models were performed in adult male Wistar rats. In the critical size model a six millimetre gap was created in the midshaft of the femur and fixed with plate and screws, while a nonunion model was established by the interposition of a spacer in the osteotomy for four weeks which resulted in compromised healing and nonunion. Albumin coated and uncoated grafts were placed into the defects. Bone healing and morphometry were evaluated by μCT and histology four weeks after implantation of the grafts. Results: In the critical size model none of the bone grafts were able to bridge the defect, and graft resorption was the typical outcome. In the nonunion model regular uncoated grafts had a low union rate (two out of six), which increased markedly when albumin coating was applied (six out of eight). Trabecular thickness and pattern factor improved significantly in the albumin coated group versus uncoated or empty controls. Conclusions: Our results showed that serum albumin coating of bone grafts can enhance the remodelling and efficacy of treatment in a nonunion model.

Original languageEnglish
Pages (from-to)741-745
Number of pages5
JournalInternational Orthopaedics
Volume37
Issue number4
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Thigh
Serum Albumin
Tomography
Transplants
Bone and Bones
Albumins
Platelet-Rich Plasma
Osteotomy
Femur
Allografts
Wistar Rats
Histology
Stem Cells

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Serum albumin enhances bone healing in a nonunion femoral defect model in rats : A computer tomography micromorphometry study. / Skaliczki, Gábor; Schandl, Károly; Weszl, Miklós; Major, T.; Kovács, Miklós; Skaliczki, József; Szendrői, M.; Dobó-Nagy, Csaba; Lacza, Z.

In: International Orthopaedics, Vol. 37, No. 4, 04.2013, p. 741-745.

Research output: Contribution to journalArticle

Skaliczki, Gábor ; Schandl, Károly ; Weszl, Miklós ; Major, T. ; Kovács, Miklós ; Skaliczki, József ; Szendrői, M. ; Dobó-Nagy, Csaba ; Lacza, Z. / Serum albumin enhances bone healing in a nonunion femoral defect model in rats : A computer tomography micromorphometry study. In: International Orthopaedics. 2013 ; Vol. 37, No. 4. pp. 741-745.
@article{9a4f5ad332814120894212739cbbbc67,
title = "Serum albumin enhances bone healing in a nonunion femoral defect model in rats: A computer tomography micromorphometry study",
abstract = "Purpose: Blood-derived proliferative factors such as platelet rich plasma or activated plasma are promising adjuvants for bone grafts. Our earlier studies showed that serum albumin itself can markedly enhance the proliferation of stem cells on bone allograft and postulated that albumin coating alone may improve bone graft integration in vivo. Methods: Two femoral defect models were performed in adult male Wistar rats. In the critical size model a six millimetre gap was created in the midshaft of the femur and fixed with plate and screws, while a nonunion model was established by the interposition of a spacer in the osteotomy for four weeks which resulted in compromised healing and nonunion. Albumin coated and uncoated grafts were placed into the defects. Bone healing and morphometry were evaluated by μCT and histology four weeks after implantation of the grafts. Results: In the critical size model none of the bone grafts were able to bridge the defect, and graft resorption was the typical outcome. In the nonunion model regular uncoated grafts had a low union rate (two out of six), which increased markedly when albumin coating was applied (six out of eight). Trabecular thickness and pattern factor improved significantly in the albumin coated group versus uncoated or empty controls. Conclusions: Our results showed that serum albumin coating of bone grafts can enhance the remodelling and efficacy of treatment in a nonunion model.",
author = "G{\'a}bor Skaliczki and K{\'a}roly Schandl and Mikl{\'o}s Weszl and T. Major and Mikl{\'o}s Kov{\'a}cs and J{\'o}zsef Skaliczki and M. Szendrői and Csaba Dob{\'o}-Nagy and Z. Lacza",
year = "2013",
month = "4",
doi = "10.1007/s00264-012-1770-8",
language = "English",
volume = "37",
pages = "741--745",
journal = "International Orthopaedics",
issn = "0341-2695",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Serum albumin enhances bone healing in a nonunion femoral defect model in rats

T2 - A computer tomography micromorphometry study

AU - Skaliczki, Gábor

AU - Schandl, Károly

AU - Weszl, Miklós

AU - Major, T.

AU - Kovács, Miklós

AU - Skaliczki, József

AU - Szendrői, M.

AU - Dobó-Nagy, Csaba

AU - Lacza, Z.

PY - 2013/4

Y1 - 2013/4

N2 - Purpose: Blood-derived proliferative factors such as platelet rich plasma or activated plasma are promising adjuvants for bone grafts. Our earlier studies showed that serum albumin itself can markedly enhance the proliferation of stem cells on bone allograft and postulated that albumin coating alone may improve bone graft integration in vivo. Methods: Two femoral defect models were performed in adult male Wistar rats. In the critical size model a six millimetre gap was created in the midshaft of the femur and fixed with plate and screws, while a nonunion model was established by the interposition of a spacer in the osteotomy for four weeks which resulted in compromised healing and nonunion. Albumin coated and uncoated grafts were placed into the defects. Bone healing and morphometry were evaluated by μCT and histology four weeks after implantation of the grafts. Results: In the critical size model none of the bone grafts were able to bridge the defect, and graft resorption was the typical outcome. In the nonunion model regular uncoated grafts had a low union rate (two out of six), which increased markedly when albumin coating was applied (six out of eight). Trabecular thickness and pattern factor improved significantly in the albumin coated group versus uncoated or empty controls. Conclusions: Our results showed that serum albumin coating of bone grafts can enhance the remodelling and efficacy of treatment in a nonunion model.

AB - Purpose: Blood-derived proliferative factors such as platelet rich plasma or activated plasma are promising adjuvants for bone grafts. Our earlier studies showed that serum albumin itself can markedly enhance the proliferation of stem cells on bone allograft and postulated that albumin coating alone may improve bone graft integration in vivo. Methods: Two femoral defect models were performed in adult male Wistar rats. In the critical size model a six millimetre gap was created in the midshaft of the femur and fixed with plate and screws, while a nonunion model was established by the interposition of a spacer in the osteotomy for four weeks which resulted in compromised healing and nonunion. Albumin coated and uncoated grafts were placed into the defects. Bone healing and morphometry were evaluated by μCT and histology four weeks after implantation of the grafts. Results: In the critical size model none of the bone grafts were able to bridge the defect, and graft resorption was the typical outcome. In the nonunion model regular uncoated grafts had a low union rate (two out of six), which increased markedly when albumin coating was applied (six out of eight). Trabecular thickness and pattern factor improved significantly in the albumin coated group versus uncoated or empty controls. Conclusions: Our results showed that serum albumin coating of bone grafts can enhance the remodelling and efficacy of treatment in a nonunion model.

UR - http://www.scopus.com/inward/record.url?scp=84885034569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885034569&partnerID=8YFLogxK

U2 - 10.1007/s00264-012-1770-8

DO - 10.1007/s00264-012-1770-8

M3 - Article

C2 - 23318937

AN - SCOPUS:84885034569

VL - 37

SP - 741

EP - 745

JO - International Orthopaedics

JF - International Orthopaedics

SN - 0341-2695

IS - 4

ER -